Physician profile
John Harkess
NPI 1366496218
$1,157.73
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2020: $158 · 2021: $423 · 2022: $11.83 · 2023: $28.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $28.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $28.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $365.61 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $158.68 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.21 | 2019-2021 | |
| Allergan, INC. | $97.16 | 2019-2020 | |
| Abbvie INC. | $91.30 | 2021-2023 | |
| Vyera Pharmaceuticals, LLC | $53.03 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $41.02 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $31.84 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $30.00 | 2019 | |
| Harmony Biosciences LLC | $17.79 | 2020 | |
| Philips North America LLC | $17.10 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $16.71 | 2019 | |
| Shire North American Group INC | $16.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15.58 | 2019 | |
| Glaxosmithkline, LLC. | $15.33 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.78 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.70 | 2021 | |
| Jazz Pharmaceuticals INC. | $13.82 | 2021 | |
| Paratek Pharmaceuticals, INC. | $13.71 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $12.74 | 2019 | |
| Mylan Specialty L.P. | $12.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Harkess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.